VALENTA FARMATSEVTIKA OAO (P) Inactive Instrument
Valenta Farmatsevtika OAO (P) Share Price
Equities
SHVZ
RU000A0JQBH4
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 31/12/98 | |
| Director/Board Member | 55 | 31/12/06 | |
| Corporate Officer/Principal | 51 | 31/12/97 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 31/12/06 | |
| Director/Board Member | - | - | |
Aleksey Romanov
BRD | Director/Board Member | - | - |
Valenta Farmatsevtika AO, formerly Valenta Farmatsevtika PAO, is a Russia-based pharmaceutical company. The Company is engaged in development, production, and market launch of prescription and Over-the-counter (OTC) medicines for such therapeutic areas as immunology, virology and antibacterial therapy, psychoneurology, gastroenterology and urology, among others. The Company's main medicines portfolio comprises brands as Ingaverin, Grammidin, Trimedat, Teraligen, Phenazepamum, Pantocalcin and Aminazine. The Company's research and production facility locates at the Schyolkovo site. Its operations cover about 56 regions of Russia, as well as Belarus, Kyrgyzstan, Azerbaijan, Armenia and Uzbekistan.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +20.37% | 43.54B | |
| +19.44% | 21.78B | |
| +17.85% | 15.38B | |
| +25.55% | 15.12B | |
| +60.99% | 13.36B | |
| -0.05% | 6.79B | |
| -15.02% | 6.38B | |
| -8.87% | 5.73B | |
| +8.17% | 5.32B |
- Stock Market
- Equities
- SHVZ Stock